FEATURES
National Poll Shows That Relatively Few Americans Admire Clinical Trial Participants For Their Contribution To Medical Science
A recent national survey of 900 adults finds that only one-third of the public greatly admires people who participate in clinical trials. This compares with 84% who greatly admire organ donors and 68% who greatly admire those who donate blood. The survey, jointly conducted in mid-December 2006 by the independent non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP) and polling firm Opinion Dynamics Corporation (ODC) is the first survey to measure public recognition of the role that clinical research participants play in advancing medical science. For detailed results of the survey,
click here.
Legislation filed to expand insurance companies' coverage of healthcare expenses for clinical research participants
Lack of coverage has been cited as a barrier for participating in a clinical trial. In one study, 60% of respondents cited a fear of having their insurance denied as the reason they decided not to participate in a trial. This can result in the patient not benefiting from a new therapy or treatment option. Determent from enrollment may also result in delaying the completion of a trial as a whole because of too few participants, potentially affecting a larger group from benefiting from those trial results.
AWARE for All Heads South for the Winter
Having delivered three successful AWARE for All programs in 2006 (Boston, Indianapolis and Philadelphia), CISCRP continues to expand the program nationally with
AWARE for All-Dallas scheduled for Saturday, March 31, 2007. AWARE-Dallas will be held in the Cityplace Conference Center located one-half mile north of downtown at 2711 North Haskell Avenue, Dallas from 9:00am to 2:30pm.
Back to top